


PLATFORM
Our revolutionary technology, DIO (Directly Induced Oocyte), is capable of producing an extremely large yield of fertilizable egg cells at a minimal cost in a fraction of the time.
We aim to create state-of-the-art solutions to a myriad of problems surrounding pregnancy, including infertility as a result of age and hereditary disorders.
Our revolutionary technology, DIO (Directly Induced Oocyte), is capable of producing an extremely large yield of fertilizable egg cells at a minimal cost in a fraction of the time.
We aim to create state-of-the-art solutions to a myriad of problems surrounding pregnancy, including infertility as a result of age and hereditary disorders.


Grow with Us
We’re looking for high-performing individuals who are passionate about science and excited to work in a collaborative environment fueled by a rigorous or entrepreneurial culture.
We’re looking for high-performing individuals who are passionate about science and excited to work in a collaborative environment fueled by a rigorous or entrepreneurial culture.

MEMBER

President and CEO
Kazuma Kishida
After graduating from Waseda University in 2020, engaged in the investment banking business at the US investment bank, Houlihan Lokey.
In 2021, he co-founded Dioseve Inc. and became CEO of the company.

Scientific Advisor
Nobuhiko Hamazaki Ph.D.
Worked as a researcher and associate professor at the Kyushu University School of Medicine from 2015 to 2020. Currently serving as HHMI Special Researcher at the University of Washington in the USA.
In 2021 he co-founded Dioseve Inc. and became the Chief Scientific Officer of the company.

Principal Scientist
Yasunari Seita Ph.D.
Obtained a Doctorate degree from Azabu University, and worked as a researcher at the Child Health Institute of New Jersey, Shiga University of Medical Science, and University of Pennsylvania.
Joined Dioseve in 2023

Senior Scientist
Kaharul Kahar
Graduated from Universiti Kuala Lumpur Royal College of Medicine Perak in 2014 and engaged in research at Kyushu University’s Hayashi Laboratory.
Joined Dioseve as Senior Scientist in 2021.

Senior Scientist
Keitaro Yamane Ph.D.
Obtained a Doctorate degree from the faculty of medicine, Osaka University in 2012 and worked at Edinburg University as a post-doctoral fellow. In 2020 engaged in Kobayashi Pharmaceutical Co., Ltd.
Joined Dioseve as Senior Scientist in 2022

Senior Scientist
Kasane Kishi DVM, Ph.D.
Obtained a Doctorate degree from the Graduate School of Agricultural and Life Sciences, The University of Tokyo in 2018 and worked as a pharmacologist in Astellas Pharma Inc.
Joined Dioseve as Senior Scientist in 2023

Scientist
Alexis Tam Ph.D.
Obtained Doctorate degree from the School of Biomedical Sciences, the University of Hong Kong in 2021 and continued to work as a post-doctoral fellow in Cheah’s Lab from the same school.
Joined Dioseve in 2022.

Scientist
Etsuko Okada
Engaged in Sanwa Kagaku Kenkyusho as a Technician in 2013.
Academic Researcher at Kumamoto University in 2019.
Joined Dioseve in 2022.

Scientist
Kazuaki Kojima Ph.D.
Obtained a Doctorate degree from Yokohama City University, and worked as researcher at the National Center for Child Health and the Central Institute for Experimental Animals.
Joined Dioseve in 2022.

Scientist
Jun Otomo
Graduated from the Department of Life and Environmental System Science, Yokohama City University in 2015. Finished Ph.D. program, Graduate School of Medicine, Kyoto University in 2020.
Work as a researcher at Peptidream Inc in 2021.
Joined Dioseve in 2023.

Scientist
Yuta Sato Ph.D.
Obtained a Doctorate degree from the Graduate School of Chemical Sciences and Engineering, Hokkaido University in 2019. Worked at Niigata University and Hokkaido University as a specially-appointed assistant professor.
Joined Dioseve in 2023.

Senior Research Associate
Orie Hikabe Ph.D.
Graduated from Keio University School of Medicine and obtained a Doctorate degree from Kyushu University’s Hayashi Laboratory.
Joined Dioseve in 2022.

Research Associate
Yusei Makino
Obtained master’s degree in Animal Reproductive Science at Graduate School of Agricultural Science, Tohoku University in 2021. After graduation, he worked as an SE at Fujitsu Inc.
Joined Dioseve in 2023.

External Advisor
Yoshinori Shiinoki
Graduated from the Department of Biopharmaceuticals, Kyoto Pharmaceutical University.
Launched the Clinical Development Department at Eli Lilly Japan and Parexel International, and since 2015, General Manager of JConsulting Management Department.

External Advisor
Nobuhiko Suganuma
M.D., Ph.D.
Professor Emeritus of Kyoto Univ. since 2018. Graduated from the Graduate School of Medicine, School of Medicine, Nagoya University. Director of Japan Society of Fertilization and Implantation. Director of Japan Society of Assisted Reproduction.
Board Chairman of Japan Society for
Uterus Transplantation.
INVESTORS


ACCESS
Headquarters
2-3-11 Nihonbashihoncho, Chuo-ku, Tokyo,
103-0023
Tokyo Laboratory
5-25-18 Hongo, Bunkyo-ku, Tokyo, 133-0033
Kumamoto Laboratory
2-2-1, Honjo, Chuo-ku, Kumamoto-shi, Kumamoto Kumamoto University, 860-8556